Discover the future
We are a technology development company commercializing discoveries in the life science industry. GeneHarmonics’ focus involves converging technologies in nanotechnology, biotechnology, and information science. GH has operations, collaborations, and partnerships in various parts of the world, specifically in Asia and the U.S.
We have point-of-care, rapid, and quantitative prototypes for diagnostic tests traditionally processed in the laboratory setting. GH has developed rapid diagnostic tests where time-sensitive results are critical to patient survival. The foundational technology is easily adaptable for additional applications – animal health testing, water testing, and food testing. Patents on the technologies and innovations have been filed in Asia and the U.S. Patents will continuously be filed as we move forward.
One Device. Different Kits. Multiple Tests.
Imagine a single device in a point-of-care setting that can generate test results for multiple biomarkers within 15 minutes.
A single, portable, multi-kit device capable of rapid testing will bring laboratory quality tests to point-of-care facilities, remote villages, and even the home.
Prototypes
Validated prototypes using FDA-approved CLSI protocols.
Pipeline
Kits and data-enabled devices for regulatory compliance.
Data
Companion data platform with AI/ML iterations.
GHHS
Better health benefits to future device end-users.
Our Management and Advisory Team
A company is only as good as the management team that leads it. Our team has a combined experience and capability to operate and make things happen across borders using various technologies. Some of our team members have worked together in various initiatives for decades. Now we are regrouping to make a difference and save lives.

Jimi Sta. Maria
Founder

Denny Roja
Executive Chairman/CEO

David Keller
COO

Rommel Roque
President – Global HR

Erin Robinson
President – Corp Dev’t

Willa Leong
Corporate Counsel

Gil Masiglat
Vice President

Lyle Larson
Corporate Advisor

Anthony Rock
Corporate Advisor

John LiSanti
Corporate Advisor

Paul Andrews
Corporate Advisor
“Saving lives through cutting-edge technology and proven strategies – now and in the future.”